SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Sala A, Barr RD. Osteopenia and cancer in children and adolescents: The fragility of success. Cancer 2007; 109: 14201431.
  • 2
    Brennan BMD, Rahim A, Adams JA, et al. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Br J Cancer 1998; 79: 18591863.
  • 3
    Halton JM, Atkinson SA, Fraher L, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr 1995; 126: 557564.
  • 4
    Rehman Q, Lane NE. Effect of glucocorticoids on bone density. Med Pediatr Oncol 2003; 41: 212216.
  • 5
    Schwartz AM, Leonidas JC. Methotrexate osteopathy. Skeletal Radiol 1984; 11: 1316.
  • 6
    Gilsanz V, Carlson ME, Roe TF, et al. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr 1990; 117: 238244.
  • 7
    Boot AM, van den Heuvel-Eibrink MM, Hählen K, et al. Bone mineral density in children with acute lymphoblastic leukemia. Eur J Cancer 1999; 35: 16931697.
  • 8
    Atkinson SA, Fraher L, Gundberg CM, et al. Mineral homeostasis and bone mass in leukemia. J Pediatr 1989; 114: 793800.
  • 9
    Hesseling PB, Hough SF, Nel ED, et al. Bone mineral density in long term survivors of childhood cancer. Int J Cancer 1998; 11: 4447.
  • 10
    Henderson RC, Madsen CD, Davis C, et al. Longitudinal evaluation of bone mineral density in children receiving chemotherapy. J Pediatr Hematol Oncol 1998; 20: 322326.
  • 11
    van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, et al. Bone mineral density, body composition and height in long term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 2000; 35: 415420.
  • 12
    Leonard MB, Propert KJ, Zemel BS, et al. Discrepancies in pediatric bone mineral density reference data: Potential for misdiagnosis of osteopenia. J Pediatr 1999; 135: 182188.
  • 13
    Horlick M, Wang J, Pierson RN, et al. Prediction models for evaluation of bone mass by dual energy X-ray absorptiometry among children and adolescents. Pediatrics 2004; 114: e337e345.
  • 14
    Bachrach LK. Consensus and controversy regarding osteoporosis in the pediatric population. Endocr Pract 2007; 13: 513520.
  • 15
    Gilsanz V, Wren T. Assessment of bone acquisition in childhood and adolescence. Pediatrics 2007; 119: S145S149.
  • 16
    Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 14: 1824.
  • 17
    Center for Disease Control and Prevention, National Center for Health Statistics 2000 CDC growth charts: United States. Available at http://www.Cdc.gov/nchs/about/major/nhanes/growthcharts/charts.htm Accessed May 30, 2001.
  • 18
    Margulies L, Horlick M, Thornton JC, et al. Reproducibility of pediatric whole body bone and body composition measures by dual energy x-ray absorptiometry using the GE lunar prodigy. J Clin Dens 2005; 8: 298304.
  • 19
    Rockett HR, Breitenbach M, Frazier AL, et al. Validation of a youth/adolescent food frequency questionnaire. Prev Med 1997; 26: 808816.
  • 20
    Slemenda CW, Reister TK, Hui SL, et al. Influences on skeletal mineralization in children and adolescents: Evidence for varying effects of sexual maturation and physical activity. J Pediatr 1994; 125: 201207.
  • 21
    Institute of medicine, food and nutrition board. Dietary reference intakes for calcium, phosphorous, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 1997.
  • 22
    Strauss AJ, Su JT, Dalton VM, et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001; 19: 30663072.
  • 23
    Brennan BMD, Mughal Z, Roberts SA, et al. Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation. J Clin Endocrinol Metab 2005; 90: 689694.
  • 24
    van der Sluis IM, de Muinck Keizer-Schrama SMPF, van den Heuvel-Eibrink MM. Bone mineral density in childhood acute lymphoblastic leukemia (ALL) during and after treatment. Pediatr Blood Cancer 2004; 43: 182183.
  • 25
    Marinovic D, Dorgeret S, Lescoeur B, et al. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: A 1-year prospective study. Pediatrics 2005; 116: e102e108.
  • 26
    Kalkwarf HJ, Khoury JC, Lanphear BP. Milk intake during childhood and adolescence, adult bone density, and osteoporotic fractures in US women. Am J Clin Nutr 2003; 77: 257265.
  • 27
    Winzenberg T, Shaw K, Fryer J, et al. Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomized controlled trials. BMJ 2006; 333: 775.
  • 28
    Alikasifoglu A, Yetfin S, Cetin M, et al. Bone mineral density and serum bone turnover markers in survivors of childhood lymphoblastic leukemia: Comparison of megadose methylprednisolone and conventional-dose prednisolone treatments. Am J Hematol 2005; 80: 113118.
  • 29
    van Beek RD, de Muinck Keizer-Schrama SMPF, Hakvoort-Cammel FG, et al. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2006; 46: 8893.
  • 30
    Chow EJ, Friedman DL, Yasui Y, et al. Decreased adult height in survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. J Pediatr 2007; 150: 370375.